2021
DOI: 10.1007/s13311-021-01012-x View full text |Buy / Rent full text
|
|

Abstract: Hypoglossal nerve stimulation (HGNS) therapy was approved in 2014 for the treatment of obstructive sleep apnea in patients who are intolerant to continuous positive airway pressure (CPAP) therapy, which is reported in up to 40-60% of patients. This therapy works via direct neurostimulation of the hypoglossal nerve in synchrony with respiration, to open the airway via tongue stiffening and protrusion. Studies have demonstrated significant reductions in both respiratory parameters such as disordered breathing in… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
2
0
1

Publication Types

Select...

Relationship

0
0

Authors

Journals